Objective Measurement of Blood Loss During Cytoreductive Surgery (CRS)

• Research type

  Research Study

• Full title

  Objective Measurement of Blood Loss During Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Pseudomyxoma Peritonei (PMP) of Appendiceal Origin and to Identify Variables Impacting Blood Loss

• IRAS ID

  359729

• Contact name

  Asoke Roy

• Contact email

  ashok.roy@hhft.nhs.uk

• Sponsor organisation

  Research and Development Hampshire Hospitals Foundation Trust

• Duration of Study in the UK

  years, 11 months, 31 days

• Research summary

  Objective blood loss measurement provides a more accurate assessment than visual estimates. This study is aimed to objectively measure and establish a preliminary framework for their use in high-blood-loss surgery, CRS and HIPEC. The findings could lay the groundwork for a larger study or standard protocol.

• REC name

  London - Surrey Borders Research Ethics Committee

• REC reference

  25/PR/1345

• Date of REC Opinion

  30 Oct 2025

• REC opinion

  Further Information Favourable Opinion